Page 5 - Best Biopsy doctors: TOP 341 doctors

HEESEOK KANGDepartment of Obstetrics

• Education/Academic career
• Graduated from Yonsei University College of Medicine
• Internship, Samsung Medical Center
• Residency and M.D., Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Pocheon Hospital
• Clinical Instructor, Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology I, Good Morning Hospital
• Head of Department, Obstetrics and Gynecology, Daerim St. Mary’s Hospital
• Director of Obstetrics and Gynecology & Academic Affairs of Medical Department , Hismedi Hospital
• Head of Department, Heryoujae Women’s Hospital
• Current)Adjunct Professor, Obstetrics and Gynecology, Samsung Medical Center
• Current)Expert for NAVER KnowledgeiN
• Professional memberships
• Award for Exemplary Safety Management, Samsung Medical Center, 2002
• Award for Excellence in QI Poster, Samsung Medical Center, 2007
• Outstanding Thesis Award, Korean Society of Gynecologic Oncology and Colposcopy, 2008
•  
• [Thesis]
•  
• 1. Single port access laparoscopic adnexal surgery. Kim TJ, Lee YY, Kim MJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. J Minim Invasive Gynecol. 2009 SepOct;16(5):6125.
• 2. The prognostic significance of the SUVmax (maximum standardized uptake value for F18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Gynecol Oncol. 2009 Oct;115(1):658. Epub 2009 Jul 15.
• 3. Singleport access laparoscopicassisted vaginal hysterectomy: a novel method with a wound retractor and a glove. Lee YY, Kim TJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. J Minim Invasive Gynecol. 2009 JulAug;16(4):4503. Epub 2009 May 31.
• 4. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a singleinstitutional phase II study. Kang H, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG. Gynecol Oncol. 2009 Aug;114(2):2104. Epub 2009 May 14.
• 5. MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node Metastasis. Ryoo UN, Choi CH, Yoon JY, Noh SK, Kang H, Kim WY, Kim BH, Kim TJ, Lee JW, Lee JH, Kim BG, Bae DS. Cancer Res Treat. 2007 Dec;39(4):16570. Epub 2007 Dec 31.
• 6. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Choi CH, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199204.
• 7. Lowgrade endometrial stromal sarcoma: a single center's experience with 22 cases. Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS. Int J Gynecol Cancer. 2008 SepOct;18(5):10849.
• 8. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Gynecol Oncol. 2008 Oct;111(1):10610.
• 9. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. BMC Cancer. 2008 Oct 11;8:295.
• 10. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. JKMS. 2009 Oct. (in press)
• 11. Ritodrine hydrochloride 단독 투여와 magnesium sulfate와의 병합 투여의 조기진통 억제효과 및 안정성에 대한 비교 김영아, 강희석, 양순하, 김종화 대한산부인과학회 2002;45:1991.
• 12. Experience of Surgical Treatment for Adnexal Lesions in Adolescent Patients 이은주, 강희석, 윤병구, 배덕수, 최두석 대한산부내시경 2002;14:79
• 13. 태아간 수혈증후군이 의심되는 단일 융모막성 쌍태임신에서 발견된 일측 쌍생아의 선천성 뇌실주위 백질 연화증 1예 강희석, 양순하, 오성희, 강병희, 노정래, 김종화 대한산부인과학회 2002:45:841
• 14. 자궁근종 치료에서 modified LAM 기법의 타당성 조사 연구 이은주, 김태중, 지현영, 김하정, 김철중, 이유영, 강희석, 최철훈, 이정원, 김병기, 배덕수 대한산부내시경 2008;20:35
• 15. 위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고 최현진, 최철훈, 김태중, 강희석, 이은주, 이정원, 김병기, 이제호, 배덕수 대한산부인과학회 2008;51:1519
• 16. Factors associated with complicationsand conversion to laparotomy in women undergoing laparoscopically assistedvaginal hysterectomy. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Acta Obstet Gynecol Scand. 2012 May;91(5):6204.
• 17. A review of the technique and complicationsfrom 2,012 cases of laparoscopically assisted vaginal hysterectomy at a singleinstitution. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):23943.
• 18. The use of misoprostol beforehysteroscopic surgery in nonpregnant premenopausal women: a randomizedcomparison of sublingual, oral and vaginal administrations. Lee YY, Kim TJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. Hum Reprod. 2010 Aug;25(8):19428.
• 19. Prognostic significance of pSTAT3 inpatients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS. J Obstet Gynaecol Res. 2010 Apr;36(2):30410.
• 20. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposideand cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.

Assoc. Prof. Ozdogan, M.D., Ph.D., completed his education at Yeditepe University Health Sciences Institute in the Molecular Medicine Doctorate Program under Prof. Dr. Turgay İsbir, and he also studied at Saint Louis University in Arkansas, USA, with Prof. Dr. M. Gazi Yasargil. He pursued a Clinical Fellowship in Brain and Nerve Surgery at Yeditepe University Hospital, guided by Prof. Dr. Yasargil and Prof. Dr. Uğur Türe. Additionally, he underwent specialization training at Ufuk University Faculty of Medicine, the Faculty of Medicine at Gazi University, and completed his secondary education at İçel Anatolian High School.

Professionally, he has held various positions, including Faculty Member in the Department of Neurosurgery at Haliç University, and Associate Professor at Private Adatip Istanbul Hospital and Biruni University Hospital. He has also served as an Associate Professor at S.B.U. Kartal, Sancaktepe, and Istanbul Training and Research Hospitals, and worked as a Chief Assistant at S.B.U. Gaziosmanpaşa Taksim and Kartal Training and Research Hospitals. His earlier roles include Specialist Doctor at S.B.U. Baltalimanı Bone Diseases Hospital and Mus State Hospital, as well as Clinical Fellow at Yeditepe University Faculty of Medicine Hospital.

Assoc. Prof. Özdoğan is a member of several professional associations, including the Turkish Neurosurgery Association, Turkish Spine Association, and the Turkish Neurosurgery Society’s Neuroanatomy, Neurovascular, and Neurooncology Groups. He is also affiliated with the European Association of Neurosurgical Societies.

Dr. Ceylan Sengul is a child development specialist who works with children aged 0-6 years. She has strong experience with developmental issues such as learning difficulties, ADHD, speech delays, and delayed toilet training. She also helps children with aggressive behaviors, eating disorders, depression, social phobia, panic attacks, addictions, and psychosomatic symptoms.

Dr. Sengul is known for treating school problems, trauma, sibling rivalry, low self-confidence, mood disorders, gender identity concerns, urinary incontinence, and body image issues. She uses evidence-based methods and has helped many children and families achieve better outcomes.

Dr. Omer Necip Aytug is a respected gastroenterologist. He graduated from Hacettepe University School of Medicine in 1980. He became an internist at Cukurova University in 1985. He completed his gastroenterology fellowship at Marmara University in 1997.

He was named Associate Professor at Firat University in 1989. In 1998, he became a Professor at Abant Izzet Baysal University. Dr. Aytug has written many scientific papers and book chapters. He has also attended several national and international congresses.

He has held important academic and clinical roles at Duzce University Faculty of Medicine, Camlica Medicana Hospital, and Memorial Service Hospital. These positions have established him as an expert in gastroenterology.

Endocrinologist

Education

MD; Hacettepe University Faculty of Medicine (2001)

Residencies

Internal Medicine; Ministry of Health Ankara Diskapi Education and Research Hospital (2009)

Pathology; Gazi University Faculty of Medicine (2004)

Fellowships

Gastroenterology and Hepatology; Necmettin Erbakan University Faculty of Medicine (2013)

Experiences

Demiroglu Bilim University Faculty of Medicine, Department of Gastroenterology and Hepatology

Istanbul Florence Nightingale Hospital (2019- currently)

Alanya Alaaddin Keykubat University Faculty of Medicine, Department of Gastroenterology and Hepatology (2017-2019)

Bundang CHA Hospital, Seoul, Korea (2018)

Konya Education and Research Hospital, Department of Gastroenterology  (2014-2017)

Certificates

Advanced Endoscopy Certificate, Bundang CHA Hospital, Seoul, Korea, 2018

Bariatric Endoscopy Certificate, Bariatric Endoscopy Global course, Sao Paulo, Brazil, 2020

Awards

2019 Rising Star, 10th Digestive Disease and Endoscopy Symposium

Memberships

Turkish Society of Internal Medicine

Turkish Society of Gastroenterology

ERCP Study Group at Turkish Society of Gastroenterology

European Society of Gastrointestinal Endoscopy

Women in Endoscopy, American Society of Gastrointestinal Endoscopy

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Areas of interest

Infertile Couple Assessment, Reproductive Difficulties, Functional Medicine, Polycystic Ovarian Disease, Endometriosis, In Vitro Fertilization, Infertility, IVF Treatments, urinary incontinence, sexual therapy, sexual dysfunction, genital aesthetics, laparoscopic surgery

Education and Expertise  

Diyarbakır Ziya Gökalp Süper High School 1995-1999 Diyarbakir Dicle University Faculty of Medicine - Medical Education 1999-2005 Diyarbakir Dicle University Faculty of Medicine Department of Physical Medicine and Rehabilitation- Specialization Training 2005-2007 Istanbul Kanuni Sultan Süleyman Teaching and Research Hospital Department of Obstetric and Gynecology Specialization Training 2007-2012

University of Health Sciences Bakirköy Dr Sadi Konuk Teaching and Research Hospital, - Research Assistant 2012-2017Istanbul Aydin University Tıp Fakültesi, department of Obstetric and Gynecology Assistant Professor 2017-2019 İstanbul Aydın University Faculty of Medicine Department of Obstetric and Gynecology Associate Professor 2019- Assisted Reproductive Therapy Certification 2019

IVF Training and Experience IAÜ VM-Medical Park Florya IVF Center, responsible physician Currently

Professional Memberships

Turkish Gynecology and Obstetrics Association

Professor of oncosurgery and proctology

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Education:

Teaching course on “Lymphatic mapping and sentinel node”

June 1998, MDA Cancer Center, Houston, Texas, USA

General Surgery

Feb. 1993 – Dec. 1996, Şişli Etfal Hospital, Istanbul, Turkey

General Surgery

May 1990 – Jan. 1993, Lille University Hospital, Lille, France 

M.D.

1983 – 1990, Cerrahpasa School of Medicine, Istanbul, Turkey

Experience

Attending General Surgeon, Jan. 1998 – present 

F.N. Metropolitan Hospital, Istanbul, Turkey

American Cancer Center, Breast Surgery

Attending General Surgeon, 1996 – present 

Medmar Diagnostic Center, Istanbul, Turkey

Diagnosis and monitoring with sophisticated techniques 

General Surgeon, 1996 – 1998

Guzelbahce Medical Center and Yeditepe Hospital, Istanbul, Turkey

Specializing in breast and thyroid surgery

Education and Specialization

• Bachelor’s Degree in Medicine (English) – Hacettepe University, 1997
• Master’s Degree – Department of Internal Medicine, Akdeniz University, 2004
• Ph.D. / Proficiency / Medical Specialization – Division of Gastroenterology, Akdeniz University, 2007

Experience

• Akdeniz University Faculty of Medicine 1998/2004
• Akdeniz University Faculty of Medicine  2004/2007
• Urfa Training and Research Hospital 2008/2009
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology  2010/2011
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2011/2013
• Akdeniz University Faculty of Medicine, Department of Internal Medicine, Division of Gastroenterology 2013/2017
• Medical Park Antalya Hospital, Gastroenterology Department and Organ Transplant Center

Dr. Hossein Taghizadeh is a highly regarded Austrian specialist in internal medicine, hematology, and medical oncology, known for his compassionate approach and commitment to personalized cancer care. With extensive experience in treating solid tumors and blood cancers, he represents a new generation of oncologists who integrate scientific progress with empathy and precision.

He studied medicine at the Medical University of Vienna, graduating in 2016, and began his residency in internal medicine and oncology shortly thereafter. His academic and clinical training at leading Austrian cancer centers equipped him with deep expertise in systemic cancer therapy, hematologic diseases, and palliative medicine.

2010–2016 – Studied medicine at the Medical University of Vienna.

2018 – Began residency in internal medicine and medical oncology, focusing on individualized treatment strategies.

2020s – Specialized in solid tumors, hematologic malignancies, and targeted therapy, contributing to multidisciplinary oncology care.

Today – Practices as an oncologist at Oncodoc and Wiener Privatklinik, providing diagnostics, systemic treatment, and follow-up for patients with gastrointestinal, urogenital, and hematologic cancers.

Dr. Taghizadeh’s clinical interests include gastrointestinal tumors, pancreatic and biliary cancers, genitourinary malignancies, and hematologic neoplasms. He works with advanced diagnostic tools and modern systemic therapies, including chemotherapy, targeted therapy, and immunotherapy.

Known for his calm professionalism, integrity, and patient-centered communication, Dr. Taghizadeh places great emphasis on evidence-based medicine and emotional support throughout the treatment journey. His work reflects a modern, holistic approach to oncology — one that values both medical excellence and the human experience behind every diagnosis.

Education

2005 – M.D., Istanbul University, Istanbul Faculty of Medicine

2010 – Internal Medicine Specialization, Haseki Training and Research Hospital

2021 – Gastroenterology Subspecialty Training, Sakarya University Faculty of Medicine

Academic & Professional Experience

Assistant Professor, Istanbul Florence Nightingale Hospital

Assistant Professor, Istanbul Bilim University Faculty of Medicine

Assistant Professor, Istanbul Yeni Yüzyıl University Faculty of Medicine

Head of Department, Giresun University Faculty of Medicine

Scientific Publications

Dr. Acar has authored over 20 international peer-reviewed articles in the fields of internal medicine and gastroenterology. Her notable contributions include studies and case reports on:

Gastrointestinal bleeding management in anticoagulant users

Rare GI cases such as bezoars, aortoesophageal fistulas, and massive hemorrhagic ascites

Liver transplantation complications, including graft-versus-host disease

The role of (pro)hepcidin in IBD-related anemia

Endoscopic interventions for acute GI bleeding

Covid-19 treatment agents and their GI implications in Turkey

(Full publication list available upon request)

Clinical Expertise

Gastrointestinal bleeding & endoscopic procedures

Hepatology & liver disease management

Inflammatory bowel diseases (IBD)

Complex GI case diagnostics

Post-transplant GI complications

Diabetic GI and cardiovascular comorbidities

Dr. Martin Schindl is a senior consultant at the University Hospital of Surgery, Vienna General Hospital. He specializes in surgery of the pancreas, liver, gallbladder, and bile ducts. He also focuses on surgical cancer therapy. Dr. Schindl leads the surgical outpatient clinic for pancreatic and biliary diseases. He coordinates the interdisciplinary pancreatic cancer group at the Comprehensive Cancer Center Vienna.

He founded the ABCSG Pancreas Working Group. Dr. Schindl reviews articles for international surgical journals. He is a member of several national and international surgical societies. He also serves on the ethics committee of the Medical University of Vienna. Dr. Schindl has made important contributions to cancer therapy research and patient support programs.

Dr. Sebastian F. Schoppmann is an expert in general and visceral surgery. He has focused on upper gastrointestinal (GI) surgery since 2007. He leads the Gastroesophageal Tumor Unit (CCC-GET) at the Comprehensive Cancer Center Vienna. He is also an Associate Professor of Surgery at the Medical University of Vienna.

Dr. Schoppmann has published over 240 peer-reviewed articles. He serves as a consulting or associate editor for several leading surgical and oncology journals. He is the General Secretary of the Austrian Society of Surgical Oncology. He has also held important leadership roles in surgical oncology organizations. His work has helped advance upper-GI cancer surgery.